Board of Trustees of The Leland Stanford Junior University’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,863
Closed -$295K 46
2021
Q4
$295K Hold
60,863
0.02% 34
2021
Q3
$368K Buy
+60,863
New +$507K 0.03% 34

Other funds holding RNXT

Board of Trustees of The Leland Stanford Junior University's RNXT Position: Q1 2022 in Review

Board of Trustees of The Leland Stanford Junior University sold out of RenovoRx (RNXT) in Q1 2022, closing a stake of 60,863 shares — an estimated $295K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in RNXT in Q3 2021 and held it in 2 quarters. The position peaked at $368K in Q3 2021. 12 funds tracked by Wall St. Rank hold RNXT as of Q1 2022.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining RenovoRx position as of Q1 2022 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 60,863 RenovoRx shares in Q1 2022, an estimated $295K.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in RenovoRx in Q3 2021 and held it in 2 quarters.
  • Board of Trustees of The Leland Stanford Junior University's RenovoRx position peaked at $368K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held RenovoRx as of Q1 2022.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2022, filed 13 May 2022.